|
| |
|
BC00113
Multiple organs tumor and normal tissue, 48 cases/48 cores tissue arrays
|
|
| Microarray Panel: | Multiple organs tumor and normal tissue microarray, 8 types of malignant tumor and normal organs (brain, lymph node, thyroid, breast, uterine cervix, ovary, prostate and kidney), single core per case |
| Cores: | 48 |
|
| Cases: | 48 |
| Layout: | 8 cols × 6 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Microarray Panel Display | Legend: | Bre - Breast,
Ceg - Cerebral gray matter,
Cer - Cerebrum,
Cew - Cerebral white and/or gray matter,
Kid - Kidney,
Lym - Lymph node,
Ova - Ovary,
Pro - Prostate,
Thr - Thyroid,
Ute - Uterine cervix
- Malignant tumor,
- NAT,
- Normal tissue
|
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Type † |
|
A1 |
1 |
M |
67 |
Cerebrum |
Astrocytoma |
3 |
Malignant |
|
A2 |
2 |
F |
42 |
Lymph node |
Hodgkin's disease |
– |
Malignant |
|
A3 |
3 |
M |
68 |
Thyroid |
Follicular papillary carcinoma |
– |
Malignant |
|
A4 |
4 |
F |
60 |
Breast |
Invasive ductal carcinoma |
2 |
Malignant |
|
A5 |
5 |
F |
62 |
Uterine cervix |
Squamous cell carcinoma |
1 |
Malignant |
|
A6 |
6 |
F |
56 |
Ovary |
Serous papillary carcinoma |
2 |
Malignant |
|
A7 |
7 |
M |
66 |
Prostate |
Undifferentiated adenocarcinoma |
|
|
|
A8 |
8 |
M |
60 |
Kidney |
Clear cell carcinoma |
– |
Malignant |
|
B1 |
9 |
F |
49 |
Cerebrum |
Large-B cell lymphoma |
– |
Malignant |
|
B2 |
10 |
M |
41 |
Lymph node |
Hodgkin's disease |
– |
Malignant |
|
B3 |
11 |
F |
30 |
Thyroid |
Papillary carcinoma |
– |
Malignant |
|
B4 |
12 |
F |
45 |
Breast |
Invasive ductal carcinoma |
2 |
Malignant |
|
B5 |
13 |
F |
76 |
Uterine cervix |
Squamous cell carcinoma |
3 |
Malignant |
|
B6 |
14 |
F |
49 |
Ovary |
Serous papillary carcinoma |
3 |
Malignant |
|
B7 |
15 |
M |
64 |
Prostate |
Adenocarcinoma |
3 |
Malignant |
|
B8 |
16 |
F |
53 |
Kidney |
Granular cell carcinoma |
– |
Malignant |
|
C1 |
17 |
M |
57 |
Cerebrum |
Malignant ependymoblastoma |
– |
Malignant |
|
C2 |
18 |
M |
43 |
Lymph node |
Diffuse B-cell lymphoma |
– |
Malignant |
|
C3 |
19 |
F |
40 |
Thyroid |
Medullary carcinoma |
– |
Malignant |
|
C4 |
20 |
F |
48 |
Breast |
Invasive ductal carcinoma |
3 |
Malignant |
|
C5 |
21 |
F |
51 |
Uterine cervix |
Squamous cell carcinoma |
2 |
Malignant |
|
C6 |
22 |
F |
24 |
Ovary |
Endodermal sinus carcinoma |
– |
Malignant |
|
C7 |
23 |
M |
72 |
Prostate |
Undifferentiated adenocarcinoma |
|
|
|
C8 |
24 |
M |
45 |
Kidney |
Chromophobe carcinoma |
– |
Malignant |
|
D1 |
25 |
F |
2 |
Cerebrum |
Normal brain tissue |
– |
Normal |
|
D2 |
26 |
M |
35 |
Lymph node |
Normal lymph node tissue |
– |
Normal |
|
D3 |
27 |
F |
58 |
Thyroid |
Normal thyroid gland tissue |
– |
Normal |
|
D4 |
28 |
F |
14 |
Breast |
Normal breast tissue |
– |
Normal |
|
D5 |
29 |
F |
58 |
Uterine cervix |
Normal cervix tissue |
– |
Normal |
|
D6 |
30 |
F |
14 |
Ovary |
Normal ovary tissue |
– |
Normal |
|
D7 |
31 |
M |
48 |
Prostate |
Normal prostate tissue |
– |
Normal |
|
D8 |
32 |
F |
14 |
Kidney |
Normal kidney tissue |
– |
Normal |
|
E1 |
33 |
F |
50 |
Cerebrum |
Normal cerebral gray matter tissue |
– |
Normal |
|
E2 |
34 |
M |
26 |
Lymph node |
Normal lymph node tissue |
– |
Normal |
|
E3 |
35 |
M |
35 |
Thyroid |
Normal thyroid gland tissue |
– |
Normal |
|
E4 |
36 |
F |
42 |
Breast |
Cancer adjacent normal breast tissue (fibrofatty tissue) |
– |
NAT |
|
E5 |
37 |
F |
38 |
Uterine cervix |
Normal cervix tissue |
– |
Normal |
|
E6 |
38 |
F |
20 |
Ovary |
Normal ovary tissue |
– |
Normal |
|
E7 |
39 |
M |
21 |
Prostate |
Cancer ajacent normal prostate tissue |
– |
NAT |
|
E8 |
40 |
F |
50 |
Kidney |
Normal kidney tissue |
– |
Normal |
|
F1 |
41 |
F |
42 |
Cerebrum |
Normal cerebral white matter tissue |
– |
Normal |
|
F2 |
42 |
M |
40 |
Lymph node |
Normal lymph node tissue |
– |
Normal |
|
F3 |
43 |
M |
37 |
Thyroid |
Normal thyroid gland tissue |
– |
Normal |
|
F4 |
44 |
F |
51 |
Breast |
Cancer adjacent normal breast tissue |
– |
NAT |
|
F5 |
45 |
F |
38 |
Uterine cervix |
Normal cervical canals tissue |
– |
Normal |
|
F6 |
46 |
F |
22 |
Ovary |
Cancer adjacent normal ovary tissue (foreign-body granuloma) |
– |
NAT |
|
F7 |
47 |
M |
27 |
Prostate |
Cancer adjacent normal prostate tissue |
– |
NAT |
|
F8 |
48 |
F |
42 |
Kidney |
Normal kidney tissue |
– |
Normal |
† For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
|
|